The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.
Inc.com
A Nobel Prize Winner’s Startup Raised $350 Million. Now It Can’t Fund Its Cancer Programs
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.